Patents by Inventor Robert Kossmann

Robert Kossmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11738125
    Abstract: Systems and methods for estimating the post-treatment ultrafiltration rate of a patient are provided. A medical device can be configured to determine an estimated post-treatment ultrafiltration rate based on one or more values associated with a patient prepared to undergo treatment with the medical device. The medical device can also be configured to compare the estimated post-treatment ultrafiltration rate with one or more threshold values. The medical device can be configured to have an alert module, which can be activated when the estimated post-treatment ultrafiltration rate exceeds the one or more threshold values.
    Type: Grant
    Filed: May 14, 2021
    Date of Patent: August 29, 2023
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Michael Singer, Shawn Sobelman, Robert Kossmann, Martin Joseph Crnkovich, Roland Levin
  • Publication number: 20210338908
    Abstract: Systems and methods for estimating the post-treatment ultrafiltration rate of a patient are provided. A medical device can be configured to determine an estimated post-treatment ultrafiltration rate based on one or more values associated with a patient prepared to undergo treatment with the medical device. The medical device can also be configured to compare the estimated post-treatment ultrafiltration rate with one or more threshold values. The medical device can be configured to have an alert module, which can be activated when the estimated post-treatment ultrafiltration rate exceeds the one or more threshold values.
    Type: Application
    Filed: May 14, 2021
    Publication date: November 4, 2021
    Inventors: Michael Singer, Shawn Sobelman, Robert Kossmann, Martin Joseph Crnkovich, Roland Levin
  • Patent number: 11007310
    Abstract: Systems and methods for estimating the post-treatment ultrafiltration rate of a patient are provided. A medical device can be configured to determine an estimated post-treatment ultrafiltration rate based on one or more values associated with a patient prepared to undergo treatment with the medical device. The medical device can also be configured to compare the estimated post-treatment ultrafiltration rate with one or more threshold values. The medical device can be configured to have an alert module, which can be activated when the estimated post-treatment ultrafiltration rate exceeds the one or more threshold values.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: May 18, 2021
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Michael Singer, Shawn Sobelman, Robert Kossmann, Martin Joseph Crnkovich, Roland Levin
  • Publication number: 20200206403
    Abstract: Systems and methods for estimating the post-treatment ultrafiltration rate of a patient are provided. A medical device can be configured to determine an estimated post-treatment ultrafiltration rate based on one or more values associated with a patient prepared to undergo treatment with the medical device. The medical device can also be configured to compare the estimated post-treatment ultrafiltration rate with one or more threshold values. The medical device can be configured to have an alert module, which can be activated when the estimated post-treatment ultrafiltration rate exceeds the one or more threshold values.
    Type: Application
    Filed: December 28, 2018
    Publication date: July 2, 2020
    Inventors: Michael Singer, Shawn Sobelman, Robert Kossmann, Martin Joseph Crnkovich, Roland Levin
  • Publication number: 20180000394
    Abstract: Embodiments of the disclosure provide a method and system for providing a diagnostic vascular window that may be used in real time to monitor a patient's fluid conditions in a variety of settings. The diagnostic vascular window may, for example, be used pre-surgery, during surgery, and post-surgery to determine whether a correct type and dose of diuretic drugs are being used for the patient. The diagnostic vascular window utilizes low flow accesses to view blood/fluids leaving and entering the patient's body. In addition, the same amount of fluids leaving the body enters the body, so there are no fluid losses or gains within the diagnostic vascular window. The low flow accesses in conjunction with a monitoring system allows for real-time measurements of blood parameters without fluid loss.
    Type: Application
    Filed: June 30, 2017
    Publication date: January 4, 2018
    Inventors: Michael Black, Louis L. Barrett, Peter Kotanko, Robert Kossmann